Literature DB >> 25527526

Cumulative contextual and individual disadvantages over the life course and adult functional somatic symptoms in Sweden.

Per E Gustafsson1, Anne Hammarström2, Miguel San Sebastian3.   

Abstract

BACKGROUND: Disadvantage, originating in one's residential context or in one's past life course, has been shown to impact on health in adulthood. There is however little research on the accumulated health impact of both neighbourhood and individual conditions over the life course. This study aims to examine whether the accumulation of contextual and individual disadvantages from adolescence to middle-age predicts functional somatic symptoms (FSS) in middle-age, taking baseline health into account.
METHODS: The sample is the age 16, 21, 30 and 42 surveys of the prospective Northern Swedish Cohort, with analytical sample size n = 910 (85% of the original cohort). FSS at age 16 and 42, and cumulative socioeconomic disadvantage, social adversity and material adversity between 16 and 42 years were operationalized from questionnaires, and cumulative neighbourhood disadvantage between 16 and 42 years from register data.
RESULTS: Results showed accumulation of disadvantages jointly explained 9-12% of FSS variance. In the total sample, cumulative neighbourhood and socioeconomic disadvantage significantly predicted FSS at age 42 in the total sample. In women, neighbourhood disadvantage but not socioeconomic disadvantage contributed significantly, whereas in men, socioeconomic but not neighbourhood disadvantage contributed significantly. In all analyses, associations were largely explained by the parallel accumulation of social and material adversities, but not by symptoms at baseline.
CONCLUSION: In conclusion, the accumulation of diverse forms of disadvantages together plays an important role for somatic complaints in adulthood, independently of baseline health.
© The Author 2014. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25527526     DOI: 10.1093/eurpub/cku213

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  6 in total

1.  Longitudinal associations between social relationships at age 30 and internalising symptoms at age 42: findings from the Northern Swedish Cohort.

Authors:  Evelina Landstedt; Per E Gustafsson; Klara Johansson; Anne Hammarström
Journal:  Int J Public Health       Date:  2015-05-30       Impact factor: 3.380

2.  Geographic variation in Alzheimer's disease mortality.

Authors:  Michael Topping; Jinho Kim; Jason Fletcher
Journal:  PLoS One       Date:  2021-07-01       Impact factor: 3.240

3.  Socioeconomic Disadvantage Moderates the Association between Peripheral Biomarkers and Childhood Psychopathology.

Authors:  Rodrigo B Mansur; Graccielle R Cunha; Elson Asevedo; André Zugman; Maiara Zeni-Graiff; Adiel C Rios; Sumit Sethi; Pawan K Maurya; Mateus L Levandowski; Ary Gadelha; Pedro M Pan; Laura Stertz; Síntia I Belangero; Márcia Kauer-Sant' Anna; Antônio L Teixeira; Jair J Mari; Luis A Rohde; Euripedes C Miguel; Roger S McIntyre; Rodrigo Grassi-Oliveira; Rodrigo A Bressan; Elisa Brietzke
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

Review 4.  What social determinants outside paid work are related to development of mental health during life? An integrative review of results from the Northern Swedish Cohort.

Authors:  Shirin Ziaei; Anne Hammarström
Journal:  BMC Public Health       Date:  2021-11-30       Impact factor: 3.295

5.  Life Course, Green Space and Health: Incorporating Place into Life Course Epidemiology.

Authors:  Jamie Pearce; Niamh Shortt; Esther Rind; Richard Mitchell
Journal:  Int J Environ Res Public Health       Date:  2016-03-17       Impact factor: 3.390

6.  Where and When: Sharpening the lens on geographic disparities in mortality.

Authors:  Wei Xu; Michal Engelman; Alberto Palloni; Jason Fletcher
Journal:  SSM Popul Health       Date:  2020-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.